Oncology Clinical Trials in Fort Wayne, IN

As of June 2026, 46 paid clinical trials are recruiting for Oncology in Fort Wayne, Indiana. Oncology trials evaluate immunotherapies, targeted therapies, antibody-drug conjugates, and combination regimens across solid tumors and blood cancers — from early-phase first-in-human studies to phase 3 registration trials. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: June 12, 2026.

Filter results

Filter results

State

City

Facility

Phase

Study type

Intervention

Recruitment status

Condition

Sex

Age

Healthy volunteers only

46 clinical trials for Oncology

·Clear filters·↓ Download CSV

Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan

for Non-Small Cell Lung Cancer

Drug: Bevacizumab

18 locations incl. Duarte

Sponsor: AbbVie

Sex: All·Age: 18+

Code: NCT05005403·Phase 1·Recruiting

Apply to this trial

A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer

for Prostate Cancer

24 locations incl. Tucson

Sponsor: Astellas Pharma Global Development, Inc.

Sex: Male·Age: 18+

Code: NCT04729114·Phase 1·Recruiting

Apply to this trial

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

for Lung Non-Small Cell Carcinoma

1150 locations incl. Anchorage

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 18+

Code: NCT04267848·Phase 3·Recruiting

Apply to this trial

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

for Carcinoma, Non-Small Cell Lung

Drug: sigvotatug vedotin

105 locations incl. Anchorage

Sponsor: Seagen, a wholly owned subsidiary of Pfizer

Sex: All·Age: 18+

Code: NCT04389632·Phase 1·Recruiting

Apply to this trial

MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles

for Breast Cancer

130 locations incl. Birmingham

Sponsor: Agendia

Sex: All·Age: 18+

Code: NCT03053193·Recruiting

Apply to this trial

Integrated Cancer Repository for Cancer Research

for Pancreatic Cancer

42 locations incl. Greenwood Village

Sponsor: University of Nebraska

Sex: All·Age: 19 - 110·Accepts healthy volunteers

Code: NCT02012699·Recruiting

Apply to this trial

Conditions in Oncology (Fort Wayne, IN)

Non-small cell lung cancer (NSCLC)· 13 Breast cancer· 8 Ovarian cancer· 6 Endometrial cancer· 4 Prostate cancer· 3 Multiple myeloma· 3 Chronic lymphocytic leukemia (CLL)· 3 Mantle cell lymphoma· 3 Melanoma· 3 Cancer (any)· 3 Pancreatic cancer· 2 Esophageal cancer· 2 Fallopian tube cancer· 2 Marginal zone lymphoma· 2 Small lymphocytic lymphoma· 2 Sarcoma· 2 Solid tumor· 2 Metastatic breast cancer· 1 Triple-negative breast cancer· 1 HER2-negative breast cancer· 1 Lung cancer· 1 Small cell lung cancer· 1 Colorectal cancer· 1 Colon cancer· 1 Rectal cancer· 1 Gastric cancer· 1 Gastroesophageal junction cancer· 1 Liver cancer· 1 Bladder cancer· 1 Kidney cancer· 1 Leukemia (other)· 1 Non-Hodgkin lymphoma· 1 Diffuse large B-cell lymphoma (DLBCL)· 1 Follicular lymphoma· 1 Skin cancer· 1 Head and neck cancer· 1 Thyroid cancer· 1 Mesothelioma· 1 Neuroendocrine tumors· 1